{"disease":{"id":"solid-tumor-unspecified-adult","name":"solid tumor unspecified adult"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06895681","title":"UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":50000,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04932525","title":"Gustave Roussy Cancer Profiling","phase":"NA","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false},{"nct_id":"NCT05695638","title":"Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Morten Ladekarl","has_results":false},{"nct_id":"NCT06885424","title":"A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":400,"lead_sponsor_name":"A2 Biotherapeutics Inc.","has_results":false},{"nct_id":"NCT04537936","title":"Psychotherapy Intervention for Latinos With Adv Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":285,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04942717","title":"Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values","phase":"NA","overall_status":"RECRUITING","enrollment_count":234,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04976803","title":"Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein","phase":"","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"Artios Pharma Ltd","has_results":false},{"nct_id":"NCT04015609","title":"Psychotherapy Intervention for Latinos With Advanced Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":190,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04443088","title":"An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":78,"lead_sponsor_name":"Shenzhen Ionova Life Sciences Co., Ltd.","has_results":false},{"nct_id":"NCT03628677","title":"A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Arcus Biosciences, Inc.","has_results":false},{"nct_id":"NCT04252339","title":"RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT04577963","title":"A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":52,"lead_sponsor_name":"Hutchmed","has_results":true},{"nct_id":"NCT06911333","title":"AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Avelos Therapeutics Inc.","has_results":false},{"nct_id":"NCT00638898","title":"Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT06883539","title":"A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"LaunXP Biomedical Co., Ltd.","has_results":false},{"nct_id":"NCT03318445","title":"Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Pamela Munster","has_results":false},{"nct_id":"NCT04169321","title":"Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Cytosite Biopharma Inc.","has_results":false},{"nct_id":"NCT05723640","title":"The Safety and Dosimetry Study of 177Lu-LNC1004 Injection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Yantai LNC Biotechnology Singapore PTE. LTD.","has_results":false},{"nct_id":"NCT04100694","title":"Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Merus B.V.","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}